EDRH
AMAG

Edmond de Rothschild Holding’s AMAG Pharmaceuticals AMAG Stock Holding History

Edmond de Rothschild Holding’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,410
Closed -$82K – 895
2016
Q2 		$82K Hold
3,410
– – ﹤0.01% 587
2016
Q1 		$80K Buy
3,410
+2,100
+160% +$49.8K ﹤0.01% 579
2015
Q4 		$40K Buy
+1,310
New +$42.3K ﹤0.01% 662

Other funds holding AMAG

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Edmond de Rothschild Holding's AMAG Position: Q3 2016 in Review

Edmond de Rothschild Holding sold out of AMAG Pharmaceuticals (AMAG) in Q3 2016, closing a stake of 3,410 shares — an estimated $82K sold.

Edmond de Rothschild Holding first reported a position in AMAG in Q4 2015 and held it in 3 quarters. The position peaked at $82K in Q2 2016. 178 funds tracked by Wall St. Rank hold AMAG as of Q3 2016.

  • Edmond de Rothschild Holding reported no remaining AMAG Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 3,410 AMAG Pharmaceuticals shares in Q3 2016, an estimated $82K.
  • Edmond de Rothschild Holding first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 3 quarters.
  • Edmond de Rothschild Holding's AMAG Pharmaceuticals position peaked at $82K in Q2 2016.
  • 178 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2016.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2016, filed 14 Nov 2016.